Personal profile
Related documents
Education/Academic qualification
博士（医学）, 東京大学
External positions
School of Medicine, Teikyo University
Sep 2024 → …
School of Medicine, Teikyo University
Sep 2021 → Aug 2024
School of Medicine, Teikyo University
Apr 2020 → Aug 2021
東京大学先端科学技術研究センター, 臨床エピジェネティクス講座, 特任研究員
Oct 2014 → Mar 2020
Second Department of Medicine, The University of Tokyo
Apr 2010 → Sep 2014
Second Department of Medicine, The University of Tokyo
Oct 2009 → Mar 2010
Second Department of Medicine, The University of Tokyo
May 2009 → Sep 2009
Second Department of Medicine, The University of Tokyo
Apr 2008 → Apr 2009
Second Department of Medicine, The University of Tokyo
Apr 2006 → Mar 2008
Research Fields
- Nephrology
- Molecular biology
- Cardiology
- Metabolism and endocrinology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Piezo1 dictates K+ homeostasis through coordinated regulation of the ubiquitin ligase Kelch-like 3 in RBCs and the kidney
Ishizawa, K., Kaseda, K., Fujii, W., Tomomitsu, Y., Hirohama, D., Yamazaki, O., Kochi, Y. & Shibata, S., 20 Jan 2026, In: Proceedings of the National Academy of Sciences of the United States of America. 123, 3, e2513222123.Research output: Contribution to journal › Article › peer-review
Open Access -
Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12
Fujii, W., Yamazaki, O., Hirohama, D., Kaseda, K., Kuribayashi-Okuma, E., Tsuji, M., Hosoyamada, M., Kochi, Y. & Shibata, S., 15 May 2025, In: Journal of Clinical Investigation. 135, 10, e186633.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Glutathione-specific gamma–glutamylcyclotransferase 1 (CHAC1) increases kidney disease risk by modulating ferroptosis
Kolligundla, L. P., Sullivan, K. M., Mukhi, D., Andrade-Silva, M., Liu, H., Guan, Y., Gu, X., Wu, J., Doke, T., Hirohama, D., Guarnieri, P., Hill, J., Pullen, S. S., Kuo, J., Inamoto, M. & Susztak, K., 23 Apr 2025, In: Science Translational Medicine. 17, 795, eadn3079.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Nonsteroidal MR antagonism in PA: clinical outcomes and unanswered questions
Hirohama, D. & Shibata, S., Jan 2025, In: Hypertension Research. 48, 1, p. 428-430 3 p.Research output: Contribution to journal › Comment/debate
Open Access -
Piezo1 and podocyte mechano-sensing in hypertensive nephropathy
Hirohama, D., 2025, (Accepted/In press) In: Hypertension Research.Research output: Contribution to journal › Comment/debate
Open Access